ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

A New Paradigm: Rethinking Hypherphosphatemia Management

Icahn School of Medicine at Mount Sinai

D. Spiegel

Physical Activity and Cardiorespiratory Fitness as Modulators of Hea…

Barry A. Franklin

Chapter 4 - How Can Primary Care Be Supported to Bridge the Chronic …

Springer Healthcare IME

S. Seidu, B. Itzhak, M. Ungan, L. Moist

Patients in Cardiometabolic Jeopardy: Evolving Strategies for Cardio…

MUSC Cardiology

D. Lloyd-Jones

Artificial Intelligence & CHAT GPT in Nephrology

University of Colorado Department of Medicine

S. Ambruso

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile

Year in Review - Obesity and Cardiovascular Kidney Syndrome: New Goa…

Samina Yunus

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina